ACIU

Quote

Short

News

Articles

Message Board

AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts

March 21, 2026 08:25:42 am

Source: SeekingAlpha

2026-03-21 08:25:42 ET

Thesis: ACI-7104 to drive upside

Read the full article on Seeking Alpha

For further details see:

AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts

AC Immune SA

NASDAQ: ACIU

ACIU Trading

-4.82% G/L:

$2.27 Last:

199,846 Volume:

$2.39 Open:

mwn-ts Ad 300

ACIU Latest News

May 22, 2026 07:00:00 am

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS

May 12, 2026 07:00:00 am

AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM

April 30, 2026 07:05:00 am

AC Immune First Quarter 2026 Financial and Corporate Updates

April 30, 2026 07:00:00 am

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease

ACIU Stock Data

Market Cap $309,766,013

Float 46,088,363

Insiders Ownership N/A

Institutions 39

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.acimmune.com

Country CH

City Lausanne

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App